Viking Therapeutics (VKTX) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Viking Therapeutics (VKTX) over the last 12 years, with Q3 2025 value amounting to $46000.0.

  • Viking Therapeutics' Other Non-Current Assets changed 0.0% to $46000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $46000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $46000.0 for FY2024, which is 3939.39% up from last year.
  • Latest data reveals that Viking Therapeutics reported Other Non-Current Assets of $46000.0 as of Q3 2025, which was down 0.0% from $46000.0 recorded in Q2 2025.
  • Over the past 5 years, Viking Therapeutics' Other Non-Current Assets peaked at $46000.0 during Q3 2024, and registered a low of $33000.0 during Q4 2021.
  • Over the past 5 years, Viking Therapeutics' median Other Non-Current Assets value was $33000.0 (recorded in 2021), while the average stood at $37062.5.
  • As far as peak fluctuations go, Viking Therapeutics' Other Non-Current Assets changed by 0.0% in 2022, and later surged by 3939.39% in 2024.
  • Quarter analysis of 5 years shows Viking Therapeutics' Other Non-Current Assets stood at $33000.0 in 2021, then changed by 0.0% to $33000.0 in 2022, then changed by 0.0% to $33000.0 in 2023, then surged by 39.39% to $46000.0 in 2024, then changed by 0.0% to $46000.0 in 2025.
  • Its Other Non-Current Assets was $46000.0 in Q3 2025, compared to $46000.0 in Q2 2025 and $46000.0 in Q1 2025.